First AI-based medical device gains government approval in South Korea

Michael Walter | | Radiology Business | Artificial Intelligence
South Korea

South Korea’s Ministry of Food and Drug Safety announced this week that, for the very first time, it has approved a medical device that uses artificial intelligence (AI) technology.

The device, VUNO’s VUNOmed-BoneAge, was developed to determine a patient’s bone age by studying x-ray images, according to a report from Korea Biomedical Review. The approval came after a clinical trial confirmed the device’s effectiveness.  

“Both the company and the ministry expect the invention will shorten the reading time by automating the manual reading of the bone age,” wrote author Lee Han-soo.

Korea Biomedical Review also reported that three other medical devices related to AI and big data are currently going through clinical trials.

Click below to read the full story.

Ministry approves Korea’s first AI-based medical device

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Related Content

Navigating the radiology workforce shortage: 6 potential solutions
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
RSNA 2024 Program Chair Kate Hanneman highlights key trends in radiology
Do large language models help or hinder workflows related to radiology reports?

Around the web

Health Imaging
Nearly $800,000 settlement offered to family of man who died during MRI exam

The patient, who was being cared for in the ICU, was not accompanied or monitored by nursing staff during his exam, despite being sedated.

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.